App
Pure Extracts Technologies Corp. to Commence Trading on the Canadian Securities Exchange (CSE)
November 03, 2020 12:00 ET | Source: Pure Extract Technologies Corp. VANCOUVER, British Columbia, Nov. 03, 2020 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (“Pure Extracts”), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, is pleased to announce that the company’s stock will commence trading on the Canadian Securities Exchange (“CSE”) under the symbol […]
CALGARY, AB, Oct. 30, 2020 – MagicMed Industries Inc. (“MagicMed” or the “Company“) is pleased to announce that it has entered into a Research Contract and a Facilities Use Agreement (“The Agreements”) with the University of Calgary. The Agreements provide MagicMed with further scientific and laboratory support to accelerate development of its psychedelic derivatives patent library, the Psybrary™. “The University of Calgary is excited […]
Just How Big is the Psychedelics Opportunity?
The North American market for psychedelic drugs is projected to reach $6.85 billion by 2027, according to Data Bridge Market Research, which represents a 16.3% compound annual growth rate. After the approval of Johnson & Johnson’s (NYSE: JNJ) SPRAVATO nasal spray for treatment-resistant depression and two Breakthrough Therapy designations, there has been an explosion of […]
Canada’s Stubborn Black-Market Cannabis Problem
Cannabis legalization came with the promise that it would prevent unnecessary incarceration, eliminate the black market and create new revenue for the government. While two of these three goals have succeeded, the black market continues to thrive in both many U.S. states and Canada despite the legalization of recreational cannabis use. Let’s take a look […]
How One Company Is Making Tryptamines & Cannabinoids Greener
Cannabinoids and tryptamines have the potential to treat a wide range of diseases, which has generated significant interest among pharmaceutical companies in accessing purified compounds. Unfortunately, these compounds are often created in agricultural or chemical synthesis processes that are time consuming, complex, expensive—and wasteful. CB Therapeutics aims to leverage its biosynthesis platform built on […]
3 Psychedelic Business Models (and What’s Best for Investors)
The psychedelics industry has captured the interest of pharmaceutical companies seeking safer and more effective products to address unmet medical needs in mental health. While psychedelic molecules have shown promise, pharmaceutical manufacturers are likely to require that the molecules be improved through scientific engineering to meet specific therapeutic goals and reduce toxicities. There are three […]
ManifestSeven: From Railroads to Fiber in California’s Cannabis Industry
California has the world’s largest cannabis market with an estimated $12 billion in annual sales. While legal cannabis sales topped $3 billion last year, the state continues to struggle to meet high expectations with logistical and other challenges. ManifestSeven Holdings Corporation (CSE: MSVN), which recently debuted on the Canadian Securities Exchange on September 30, aspires […]
Christina Lake Cannabis Completes Commissioning of CO2 Extraction Equipment
VANCOUVER, British Columbia, OCTOBER 15, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce it has completed the commissioning of its Vitalis Extraction Technology R200H-GMP-SS extraction system. The news comes days after revealing the Company has met its first-year cannabis production forecast of 22,500 kg, which will […]
CB Therapeutics Targets Psychedelics & Cannabis Markets
There’s little question that the market for cannabinoids and psychedelics are poised to experience significant growth over the coming years. While the demand for cannabinoids, like cannabidiol (CBD), has already seen tremendous growth, psychedelics represent a blue-sky market due to the potential to treat a wide range of mental health disorders. Let’s take a look […]
Who’s Who in Psychedelic Clinical Trials
The psychedelic drug market could reach $6.85 billion by 2027, according to Data Bridge Market Research, which translates to a blistering 16.3% compound annual growth rate. As psychedelic treatments enter clinical trials, investors may want to keep an eye on the companies behind them as potentially coming first-to-market with revolutionary drugs. Let’s take a […]
Pure Extracts Secures Processing License from Health Canada
Canada’s cannabis industry has exploded in size over the past few years. With more cultivation coming online, the retail price of cannabis biomass has fallen to about $5 per gram (including taxes) during the first quarter. The legalization and consumer trend towards cannabis extracts means that much of that dried cannabis is being processed […]
Christina Lake Cannabis Adds Sales and Business Development Leadership to its Roster
VANCOUVER, British Columbia, OCTOBER 6, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) a premier producer of high quality, low cost, sun-grown cannabis flower, oil cannabinoids and hemp-based extracts and derivatives, serving domestic and international markets, is pleased to announce that they have hired Rob Jones as Executive Vice President […]
Why Location Matters in Cannabis
The global cannabis industry has projected to be worth $73.6 billion by 2027, according to Grand View Research, which represents a blistering 18.1% compound annual growth rate. While cannabis has historically been grown indoors, outdoor cultivation has become increasingly popular over the past couple of years. Let’s take a look at the benefits of outdoor […]
Why Psychedelic Delivery Mechanisms Matter
The psychedelics industry is poised to become a nearly $7 billion market by 2027, according to Data Bridge Market Research, driven by the potential to revolutionize the treatment of mental health disorders. While investors have many options in the space, the best positioned companies are combining delivery mechanisms with novel compounds to create IP […]
Building a Cannabis Conglomerate
Investors don’t have to look hard to find conglomerates in the alcoholic beverage industry—a close proxy for the recreational cannabis industry. AB InBev (NYSE: BUD) generates about $50 billion per year in sales with more than 400 beer brands while Diageo (NYSE: DEO) generates over £10 billion in annual sales with many popular liquor […]
Christina Lake Cannabis Announces Commencement of Trading on the CSE
VANCOUVER, British Columbia, OCTOBER 1, 2020 – Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) is pleased to announce that its common shares will begin trading today on the Canadian Securities Exchange (“CSE”) at 9:30 am EDT on Thursday October 1, 2020 under the ticker symbol “CLC”. Christina Lake Cannabis is […]
‘Amazon of Cannabis’ ManifestSeven Makes Its Debut on the CSE
ManifestSeven Holdings Corporation (CSE: MSVN) began trading on the Canadian Securities Exchange on Wednesday. With its reverse takeover complete and its listing on the CSE launched, the first integrated omnichannel platform for legal cannabis achieved a critical milestone and set the stage for expansion over the coming year. “The listing equips M7 with an […]
Pure Extract Technologies Inc. Receives Health Canada Standard Processing License
Vancouver, B.C., September 30, 2020 – Big Sky Petroleum Corporation (TSX-V: BSP.H) (“Big Sky”) and Pure Extract Technologies Inc. (“Pure Extracts”) are pleased to announce that further to the Big Sky news release dated February 19, 2020 announcing its proposed acquisition (the “Proposed Transaction”) of Pure Extracts, pursuant to which Big Sky will acquire all of the […]
DENVER, Colorado, USA – September 30th, 2020 – Mydecine Innovations Group, Inc., (CSE:MYCO) (OTC:MYCOF) (FSE:0NFA) (“Mydecine” or the “Company”) is pleased to announce that its subsidiary Mindleap Health (“Mindleap”), a digital telehealth mobile application for mental coaching and wellbeing, has officially launched and is available for download today: Download on Android Download on IOS […]
Christina Lake Announces Commencement of Trading on the CSE
September 29, 2020 17:11 ET | Source: Christina Lake Cannabis Corp. VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”), a premier producer of high-quality, low-cost, sun-grown cannabis flower, oil cannabinoids, as well as hemp-based extracts and derivatives, serving domestic and international markets, is pleased to announce […]
ManifestSeven To Begin Trading On The Canadian Securities Exchange
September 29, 2020 06:15 PM Eastern Daylight Time LOS ANGELES & IRVINE, Calif.–(BUSINESS WIRE)–ManifestSeven Holdings Corporation (formerly P&P Ventures Inc.) (“M7” or the “Company”), California’s first integrated omnichannel platform for legal cannabis, today announces that, in connection with the completion of its reverse takeover transaction announced in its September 25, 2020 news release, the Company’s Class […]
MindLeap Health Enters into Fast-Growing Telehealth Market
The COVID-19 pandemic has led to dramatic changes in healthcare. In addition to mobilizing a vaccine in record time, the pandemic could permanently alter the way that many people seek medical care, shifting from in-person to telehealth. These changes have created an enormous opportunity for companies to innovate in the remote delivery of health services. […]
How the Psybrary™ Could Revolutionize Psychedelic Drug Discovery
The psychedelic drug market is projected to grow at a compound annual growth rate of 16.3% over the next eight years to reach $6.85 billion by 2026, according to Data Bridge Market Research. With the potential to treat a wide range of mental health disorders, several organizations are already conducting clinical trials in the space. […]
ManifestSeven Raises Capital & Looks to Go Public
ManifestSeven, California’s first integrated omnichannel platform for legal cannabis, recently closed an aggregate $10.2 million capital raise consisting of three private placements. In addition to affirming its business model, the capital raise injects fresh funding into the company’s ambitious plan to become the Amazon of cannabis. Let’s take a closer look at the company’s innovative […]
Pure Extracts: A Proven Extraction Company with Laser Focus
Investors familiar with the cannabis and psychedelics industry know that most publicly traded companies are reverse mergers orchestrated by financiers. With strong investor interest, these financiers focused on raising as much capital as possible before starting to build a tangible business – many didn’t even have experience in the cannabis or psychedelics space! Of […]
Cybin Corp.: A Psychedelics Pioneer Led by a Biotech Veteran
Cybin has become one of the most popular psychedelic companies over the past year. With a unique approach to the market and an experienced management team, the company aims to bring a breakthrough psychedelic therapy to market for those suffering from Major Depressive Disorder and other mental health conditions—and build value for shareholders in the […]
MagicMed Closes Oversubscribed $1.6M Private Placement to Build Out Its Psybrary™
The burgeoning psychedelics sector in many ways resembles the cannabis industry of a decade ago. With rising interest in psychedelic medicine, analysts project that the market could grow at a 16.3% compound annual growth rate to $6.85 billion by 2027. There are a growing number of companies participating in the industry, most of which […]
Full Spectrum: The Next Revolution in Extraction
The cannabis industry has rapidly matured over the past few years as legalization has swept North America and other parts of the world. While cannabis flower and distillates dominated the early market, patient and consumer preferences have shifted toward higher-quality products that provide more benefits—such as full-spectrum cannabis oils. Let’s take a look at the […]
Why You Should Invest in Psychedelic ‘Platform Plays’
The psychedelics industry has experienced tremendous growth over the past year. In addition to regulatory support and decriminalization, many companies have either gone public or raised capital and investors have a growing number of options when it comes to building exposure into their portfolio—including both product and platform opportunities. Let’s take a look at […]
What Are Functional Mushrooms?
Most people think of white buttons at the grocery store when they think of mushrooms, but in reality, there are hundreds of different kinds of mushrooms. Functional mushrooms—like functional foods and beverages—are mushroom varieties that provide a health benefit, ranging from run-of-the-mill vitamins and minerals to important nutrients, including selenium, potassium, riboflavin, niacin, proteins, […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe and Latin America and the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, […]
Weekend Unlimited aggregates and scales small to medium cannabis brands in flower, extracts, and edibles.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
